These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31757401)

  • 1. Embolisation of prostate arteries in benign prostatic hyperplasia in non-surgical patients.
    Monreal R; Robles C; Sánchez-Casado M; Ciampi JJ; López-Guerrero M; Ruíz-Salmerón RJ; Lanciego C
    Radiologia (Engl Ed); 2020; 62(3):205-212. PubMed ID: 31757401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Embolisation of prostatic arteries as treatment of moderate to severe lower urinary symptoms (LUTS) secondary to benign hyperplasia: results of short- and mid-term follow-up.
    Pisco JM; Rio Tinto H; Campos Pinheiro L; Bilhim T; Duarte M; Fernandes L; Pereira J; Oliveira AG
    Eur Radiol; 2013 Sep; 23(9):2561-72. PubMed ID: 23370938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostatic artery embolization in benign prostatic hyperplasia: preliminary results in 13 patients.
    Grosso M; Balderi A; Arnò M; Sortino D; Antonietti A; Pedrazzini F; Giovinazzo G; Vinay C; Maugeri O; Ambruosi C; Arena G
    Radiol Med; 2015 Apr; 120(4):361-8. PubMed ID: 25245496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate artery embolisation for benign prostatic hyperplasia: a systematic review and meta-analysis.
    Malling B; Røder MA; Brasso K; Forman J; Taudorf M; Lönn L
    Eur Radiol; 2019 Jan; 29(1):287-298. PubMed ID: 29948079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate Artery Embolization for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Results From a Prospective FDA-Approved Investigational Device Exemption Study.
    Salem R; Hairston J; Hohlastos E; Riaz A; Kallini J; Gabr A; Ali R; Jenkins K; Karp J; Desai K; Thornburg B; Casalino D; Miller F; Hofer M; Hamoui N; Mouli S
    Urology; 2018 Oct; 120():205-210. PubMed ID: 30036614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate artery embolisation: an all-comers, single-operator experience in 159 patients with lower urinary tract symptoms, urinary retention, or haematuria with medium-term follow-up.
    Thulasidasan N; Kok HK; Elhage O; Clovis S; Popert R; Sabharwal T
    Clin Radiol; 2019 Jul; 74(7):569.e1-569.e8. PubMed ID: 30955835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised Clinical Trial of Prostatic Artery Embolisation Versus a Sham Procedure for Benign Prostatic Hyperplasia.
    Pisco JM; Bilhim T; Costa NV; Torres D; Pisco J; Pinheiro LC; Oliveira AG
    Eur Urol; 2020 Mar; 77(3):354-362. PubMed ID: 31831295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial Canadian Experience of Prostate Artery Embolization for Symptomatic Benign Prostatic Hyperplasia: Midterm Outcomes.
    Patel NR; Elterman DS; Thulasidasan N; Altman R; Tai E; Zener R; Stella SF; Annamalai G; Mafeld S; Simons ME
    Can Assoc Radiol J; 2021 Nov; 72(4):876-882. PubMed ID: 32673069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does polyvinyl alcohol particle size change the outcome of prostatic arterial embolization for benign prostatic hyperplasia? Results from a single-center randomized prospective study.
    Bilhim T; Pisco J; Campos Pinheiro L; Rio Tinto H; Fernandes L; Pereira JA; Duarte M; Oliveira AG
    J Vasc Interv Radiol; 2013 Nov; 24(11):1595-602.e1. PubMed ID: 23916874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexual and functional outcomes of prostate artery embolisation: A prospective long-term follow-up, large cohort study.
    Al Rawashdah SF; Pastore AL; Velotti G; Fuschi A; Capone L; Suraci PP; Martoccia A; Saltarelli A; Minucci S; Falsaperla M; Al Salhi Y; Illiano E; Costantini E; Carbone A
    Int J Clin Pract; 2020 Mar; 74(3):e13454. PubMed ID: 31769906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostatic arterial embolization for the treatment of lower urinary tract symptoms caused by benign prostatic hyperplasia: a comparative study of medium- and large-volume prostates.
    Wang M; Guo L; Duan F; Yuan K; Zhang G; Li K; Yan J; Wang Y; Kang H
    BJU Int; 2016 Jan; 117(1):155-64. PubMed ID: 25851432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early results from a United States trial of prostatic artery embolization in the treatment of benign prostatic hyperplasia.
    Bagla S; Martin CP; van Breda A; Sheridan MJ; Sterling KM; Papadouris D; Rholl KS; Smirniotopoulos JB; van Breda A
    J Vasc Interv Radiol; 2014 Jan; 25(1):47-52. PubMed ID: 24176946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostatic artery embolization for the treatment of symptomatic benign prostatic hyperplasia in men ≥75 years: a prospective single-center study.
    Wang MQ; Wang Y; Yan JY; Yuan K; Zhang GD; Duan F; Li K
    World J Urol; 2016 Sep; 34(9):1275-83. PubMed ID: 26818021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unilateral versus bilateral prostatic arterial embolization for lower urinary tract symptoms in patients with prostate enlargement.
    Bilhim T; Pisco J; Rio Tinto H; Fernandes L; Campos Pinheiro L; Duarte M; Pereira JA; Oliveira AG; O'Neill J
    Cardiovasc Intervent Radiol; 2013 Apr; 36(2):403-11. PubMed ID: 23232858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate artery Embolisation Assessment of Safety and feasibilitY (P-EASY): a potential alternative to long-term medical therapy for benign prostate hyperplasia.
    Brown N; Walker D; McBean R; Pokorny M; Kua B; Gianduzzo T; Dunglison N; Esler R; Yaxley J
    BJU Int; 2018 Nov; 122 Suppl 5():27-34. PubMed ID: 30076682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostatic artery embolization in treating benign prostatic hyperplasia: a systematic review.
    Teoh JY; Chiu PK; Yee CH; Wong HM; Chan CK; Chan ES; Hou SS; Ng CF
    Int Urol Nephrol; 2017 Feb; 49(2):197-203. PubMed ID: 27896579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Clinical Outcomes of Prostatic Artery Embolization with 50-μm Plus 100-μm Polyvinyl Alcohol (PVA) Particles versus 100-μm PVA Particles Alone: A Prospective Randomized Trial.
    Wang MQ; Zhang JL; Xin HN; Yuan K; Yan J; Wang Y; Zhang GD; Fu JX
    J Vasc Interv Radiol; 2018 Dec; 29(12):1694-1702. PubMed ID: 30297313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study).
    Ray AF; Powell J; Speakman MJ; Longford NT; DasGupta R; Bryant T; Modi S; Dyer J; Harris M; Carolan-Rees G; Hacking N
    BJU Int; 2018 Aug; 122(2):270-282. PubMed ID: 29645352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prostatic arterial embolization for benign prostatic hyperplasia in high-risk aged males].
    Yan WH; Zhang C; Al GP; Shu Y
    Zhonghua Nan Ke Xue; 2015 Oct; 21(10):900-3. PubMed ID: 26665678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of 5-Alpha-Reductase Inhibitors Use at the Time of Prostatic Artery Embolization for Treatment of Benign Prostatic Obstruction.
    Cardarelli-Leite L; de Assis AM; Moreira AM; Antunes AA; Cerri GG; Srougi M; Carnevale FC
    J Vasc Interv Radiol; 2019 Feb; 30(2):228-232. PubMed ID: 30717954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.